Matthew Feinstein, a Third Coast CFAR Pilot Awardee, will speak at the “HIV and CVD: Reducing Cardiovascular Risk in Patients with HIV/AIDS” event on March 17. With Priscilla Hsue, MD, FACC, they will address the specific need of cardiovascular practitioners, family practice physicians and infectious disease specialists to understand the importance of the intersection between cardiovascular disease (CVD) and HIV infection, the impact of antiretroviral therapy (ART) on cardiovascular (CV) risk, and the ability to implement recommended risk-reduction approaches to reduce the patients’ risk of CVD.
Recent Posts
- TC CFAR Hiring for New Program Assistant 4 Position
- ISCI’s Visiting Scholars in HIV Implementation Science Program Application Deadline Extended Until Jan. 12
- NIH Summer Institute on Behavioral Clinical Trials Applications Due Jan. 31
- NUCATS K12 Career Development Program Letter of Intent Due Feb. 3
- Lighthouse Foundation Honors Black LGBTQ+ Community with World AIDS Day Event
- ISCI Opens Applications for 2025 Practitioner-Oriented Implementation Science Education (POISE) Training Program